ARTICLE | Distillery Therapeutics
Musculoskeletal
January 23, 2019 12:08 AM UTC
Cell culture and mouse studies identified a bicyclic HSD17B2 inhibitor that could help treat bone fractures. Chemical synthesis and testing in enzyme activity assays of bicyclic hydroxyphenylmethanone...
BCIQ Company Profiles
BCIQ Target Profiles